What really causes Alzheimer's and how might we fix it?

by John Hewitt , Medical XpressCredit: mediologiest.comThere have been a lot of theories about what causes Alzheimer's disease. Many of them have given rise to experimental treatments of one form

Updated on: April 29,2024

What really causes Alzheimer's and how might we fix it?

by John Hewitt , Medical XpressCredit: mediologiest.comThere have been a lot of theories about what causes Alzheimer's disease. Many of them have given rise to experimental treatments of one form

Updated on:April 29,2024

Florida doctors use saliva test to reveal someone's future risk for Alzheimer's

by Cindy Krischer GoodmanCredit: Pixabay/CC0 Public DomainFlorida doctors are using a new test to determine someone's future risk for Alzheimer's disease from a few drops of spit.At a time whe

Updated on: June 01,2024

Florida doctors use saliva test to reveal someone's future risk for Alzheimer's

by Cindy Krischer GoodmanCredit: Pixabay/CC0 Public DomainFlorida doctors are using a new test to determine someone's future risk for Alzheimer's disease from a few drops of spit.At a time whe

Updated on:June 01,2024

Generative AI helps to explain human memory and imagination

JANUARY 19, 2024byUniversity College LondonCredit: Pixabay/CC0 Public DomainRecent advances in generative AI help to explain how memories enable us to learn about the world, relive old experienc

Updated on: March 13,2024

Generative AI helps to explain human memory and imagination

JANUARY 19, 2024byUniversity College LondonCredit: Pixabay/CC0 Public DomainRecent advances in generative AI help to explain how memories enable us to learn about the world, relive old experienc

Updated on:March 13,2024

Brain neurotransmitter receptor antagonist found to prevent opioid addiction in mice

byUniversity of California, Los AngelesSuvorexant blocked microglial activation in the hypothalamus and VTA. Credit:Nature Mental Health(2024). DOI: 10.1038/s44220-024-00278-2New res

Updated on: July 10,2024

Brain neurotransmitter receptor antagonist found to prevent opioid addiction in mice

byUniversity of California, Los AngelesSuvorexant blocked microglial activation in the hypothalamus and VTA. Credit:Nature Mental Health(2024). DOI: 10.1038/s44220-024-00278-2New res

Updated on:July 10,2024

Alzheimer's disease: Reduced signals in the brain's forgotten cells

by University of OsloAssociate Professor Rune Enger at the Institute of Basic Medical Sciences at the University of Oslo. Credit: Cecilie Bakken Høstmark, UiOAlzheimer's disease is associated

Updated on: April 02,2024

Alzheimer's disease: Reduced signals in the brain's forgotten cells

by University of OsloAssociate Professor Rune Enger at the Institute of Basic Medical Sciences at the University of Oslo. Credit: Cecilie Bakken Høstmark, UiOAlzheimer's disease is associated

Updated on:April 02,2024

4D printing allows flexible electrodes for nerve stimulation

byTechnical University MunichFor the conductive structures, a thin layer of gold is deposited onto the 3D printed structure under high vacuum. Credit: Andreas Heddergott / TUMSpecific nerves may

Updated on: January 21,2024

4D printing allows flexible electrodes for nerve stimulation

byTechnical University MunichFor the conductive structures, a thin layer of gold is deposited onto the 3D printed structure under high vacuum. Credit: Andreas Heddergott / TUMSpecific nerves may

Updated on:January 21,2024

Insights on brain-spinal communication in opioid withdrawal lead to a clinical trial

byUniversity of CalgaryTuan Trang (left) and Lori Montgomery discuss the clinical trial using an anti-gout medication to address the severe symptoms of of opioid withdrawal. Credit: Riley Brandt

Updated on: September 06,2024

Insights on brain-spinal communication in opioid withdrawal lead to a clinical trial

byUniversity of CalgaryTuan Trang (left) and Lori Montgomery discuss the clinical trial using an anti-gout medication to address the severe symptoms of of opioid withdrawal. Credit: Riley Brandt

Updated on:September 06,2024

Testing effectiveness of a mobile app for assessment of dementia symptoms

by Regenstrief InstituteRegenstrief Institute research scientist Daniel Bateman, M.D. is testing the effectiveness of Brain CareNotes , a novel mobile app for assessment of dementia symptoms. Cre

Updated on: May 05,2024

Testing effectiveness of a mobile app for assessment of dementia symptoms

by Regenstrief InstituteRegenstrief Institute research scientist Daniel Bateman, M.D. is testing the effectiveness of Brain CareNotes , a novel mobile app for assessment of dementia symptoms. Cre

Updated on:May 05,2024

Number of Americans with dementia will double by 2040: Report

(HealthDay)—Nearly 13 million Americans will have dementia by 2040—nearly twice as many as today, a new report says.The number of women with dementia is expected to rise from 4.7 million next year to

Updated on: April 29,2024

Number of Americans with dementia will double by 2040: Report

(HealthDay)—Nearly 13 million Americans will have dementia by 2040—nearly twice as many as today, a new report says.The number of women with dementia is expected to rise from 4.7 million next year to

Updated on:April 29,2024

Exposure to traffic noise linked to higher dementia risk

by British Medical JournalCredit: Unsplash/CC0 Public DomainExposure to noise from traffic on roads and railways over a long period is associated with a higher risk of developing dementia, especi

Updated on: June 24,2024

Exposure to traffic noise linked to higher dementia risk

by British Medical JournalCredit: Unsplash/CC0 Public DomainExposure to noise from traffic on roads and railways over a long period is associated with a higher risk of developing dementia, especi

Updated on:June 24,2024

Prolonging the effects of botulinum therapy: A milestone in neuromuscular disease management

by Shimane UniversityAntibody administration following saline or BTX administration at the beginning of the treatment. Anti-IGF1R antibody treatment is denoted as IGF1R and control IgG antibody treatm

Updated on: January 10,2024

Prolonging the effects of botulinum therapy: A milestone in neuromuscular disease management

by Shimane UniversityAntibody administration following saline or BTX administration at the beginning of the treatment. Anti-IGF1R antibody treatment is denoted as IGF1R and control IgG antibody treatm

Updated on:January 10,2024

Stimulating axon regrowth after spinal cord injury

by Burke Neurological InstituteCredit: Pixabay/CC0 Public DomainA new study by Burke Neurological Institute (BNI), Weill Cornell Medicine, finds that activation of MAP2K signaling by genetic engineeri

Updated on: February 18,2024

Stimulating axon regrowth after spinal cord injury

by Burke Neurological InstituteCredit: Pixabay/CC0 Public DomainA new study by Burke Neurological Institute (BNI), Weill Cornell Medicine, finds that activation of MAP2K signaling by genetic engineeri

Updated on:February 18,2024